| Literature DB >> 27990462 |
Serafino Carta1, Mattia Fortina1, Alberto Riva1, Luigi Meccariello1, Enrico Manzi1, Antonio Di Giovanni1, Paolo Ferrata1.
Abstract
Introduction. The periprosthetic fracture of the femur is, in order of frequency, the fourth leading cause (5.9%) of surgical revision. Our study aims to demonstrate how the grafting of bone splint betters the outcomes. Materials. We treated 15 periprosthetic femoral fractures divided into two groups: PS composed of 8 patients treated with plates and splints and PSS involving 7 patients treated only with plates. The evaluation criteria for the two groups during the clinical and radiological follow-up were the quality of life measured by the Short Form (36) Health Survey (SF-36), Harris Hip Score (HHS), Modified Cincinnati Rating System Questionnaire (MCRSQ), bone healing measured by the Radiographic Union Score (RUS), postoperative complications, and mortality. The evaluation endpoint was set at 24 months for both groups (p < 0.05). Results. The surgery lasted an average of 124.5 minutes for the PS group and 112.6 minutes for the PSS. At 24 months all clinical and radiographic scores were p < 0.05 for the PS group. During follow-up 4 patients (2 in each group) died of causes not related to surgery. Conclusions. The use of the metal plate as opposed to cortical allogenic splint should be taken into consideration as a noteworthy point for periprosthetic femoral fractures.Entities:
Year: 2016 PMID: 27990462 PMCID: PMC5136380 DOI: 10.1155/2016/2918735
Source DB: PubMed Journal: Adv Med ISSN: 2314-758X
Description of population.
| PS | PSS | |
|---|---|---|
| Number of patients | 8 | 7 |
|
| ||
| Average of age in years | 77.8 | 75.3 |
|
| ||
| Range of patients age in years | 70–89 | 67–81 |
|
| ||
| Gender ratio (m : f) | 0.6 (3 : 5) | 0.75 (3 : 4) |
|
| ||
| Fractures type according to Vancouver and Rorabeck classification | Vancouver B2: 2 | Vancouver B2: 2 |
|
| ||
| ASA physical status classification system | ASA I: 0 | ASA I: 0 |
|
| ||
| Number of patients that needed a place in intensive care | 5 (62.5%) | 5 (71.42%) |
|
| ||
| Patients treated for osteoporosis | 4 (50%) | 6 (85.71%) |
|
| ||
| Average years of follow-up after periprosthetic fracture | 2.3 | 2.3 |
|
| ||
| Range of years of follow-up after periprosthetic fracture | 1–4 | 1–5 |
Patients' comorbidity.
| PS (%) | PSS number (%) | |
|---|---|---|
| Comorbidity | ||
| Cardiovascular diseases | 6 (75%) | 5 (71.42%) |
| Stroke | 4 (50%) | 1 (14.29%) |
| Respiratory diseases | 5 (62.5%) | 6 (85.71%) |
| Nefro-urologic diseases | 5 (62.5%) | 2 (28.57%) |
| Diabetes mellitus | 4 (50%) | 6 (85.71%) |
| Rheumatic diseases | 4 (50%) | 7 (100%) |
| Parkinson's disease | 1 (12.5%) | 2 (28.57%) |
| Smokers | 1 (12.5%) | 3 (42.86%) |
| Use of steroids | 7 (87.5%) | 7 (100%) |
| Number of comorbidities for patient | ||
| 1 | 1 (12.5%) | 1 (14.29%) |
| 2 | 2 (25%) | 1 (14.29%) |
| ≥3 | 5 (62.5%) | 5 (71.42%) |
Figure 1Trend of the follow-up to two years of quality of life measured by the Short Form (36) Health Survey (SF-36). At the sixth month of follow-up there was already a statistically significant difference (p < 0.05) in favor of the PS Group.
Figure 2Trend hip function and quality of life related to it for 2-year follow-up measured by Harris Hip Score (HHS). At six months there was a statistically significant difference (p < 0.05) in favor of the PS group.
Figure 3Trend of knee function and quality of life related to it for two-year follow-up measured by the Modified Cincinnati Rating System Questionnaire (MCRSQ). At twelve months there was a statistically significant difference (p < 0.05) in favor of the PS group.
Figure 4Trend of bone healing in two-year follow-up measured by Radiographic Union Score (RUS). At the twelfth month there was a statistically significant difference (p < 0.05) in favor of the PS group.
Postoperative complications during all the follow-up.
| PS (%) | PSS (%) | |
|---|---|---|
| Respiratory infections | 1 (12.5%) | 1 (14.29%) |
| Cardiac failure | 2 (25%) | 3 (42.86%) |
| DVE (Deep Venous Thrombosis) | 0 (0%) | 0 (0%) |
| Urinary infection | 0 (0%) | 2 (28.57%) |
| Gastrointestinal bleeding | 0 (0%) | 2 (28.57%) |
| Myocardial infarction | 2 (25%) | 2 (28.57%) |
| Ictus/tia | 1 (12.5%) | 2 (28.57%) |
| Number of complications for patient: | ||
| 1 | 1 (12.5%) | 1 (14.29%) |
| 2 | 1 (12.5%) | 2 (28.57%) |
| ≥3 | 1 (12.5%) | 2 (28.57%) |
| Numbers of deaths | ||
| After two years of follow-up | 2 (25%) | 2 (28.57%) |